Mounjaro®
Starting from £179.99/mo
Start journey Learn moreDiarrhoea is one of the more common side effects reported with tirzepatide, particularly in the early weeks of treatment or after a dose increase. Most people who experience it find it short-lived and manageable, but knowing what to expect — and what genuinely warrants a call to your prescriber — makes a real difference. These are prescription-only medicines, and suitability, dosing and side-effect management should always be guided by a clinician who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide works partly by slowing the rate at which food leaves the stomach. That change in gastric emptying affects the whole digestive tract downstream, which is why loose stools and diarrhoea feature alongside nausea and constipation in the reported side-effect profile. If you are wondering whether tirzepatide can actually cause diarrhoea, the short answer is yes, and it is one of the more commonly reported GI effects. The GI effects reflect your gut adapting to a new hormonal signal, not a sign the treatment is damaging anything.
According to the NHS medicines page for tirzepatide, diarrhoea is listed among the common side effects, meaning it affects somewhere between 1 in 10 and 1 in 100 people. The timing matters: if it begins shortly after you started treatment or shortly after a dose step, that pattern fits exactly what the clinical evidence describes. For a fuller picture of the broader Mounjaro side effects profile, there is dedicated guidance on what to watch for at each stage.
Pay attention to whether the diarrhoea is mild and intermittent or severe and continuous. Frequency, duration and whether you can keep fluids down are the details your prescriber will ask about, it helps to note them before you call.
Hydration is the immediate priority. Diarrhoea depletes fluids and electrolytes faster than most people expect, so sipping water steadily through the day (rather than large amounts at once) is more effective than waiting until you feel thirsty. Oral rehydration sachets are available over the counter and are worth considering if loose stools are frequent.
On the dietary side, sticking to smaller, lower-fat meals while GI symptoms are active tends to reduce the load on a gut that is already adjusting. Understanding why tirzepatide causes diarrhoea can help make sense of why high-fat meals generally worsen GI side effects regardless of individual variation. Avoid foods that are already fast-acting gut irritants for you personally. There is specific practical guidance on managing tirzepatide-related diarrhoea if you want more detail on day-to-day approaches.
Timing of the injection can occasionally affect symptoms, some people find that injecting on a day when they can stay close to home helps psychologically, though this does not change the underlying pharmacology. Any change to your injection schedule should only happen after discussing it with your prescriber.
Do not reduce your dose or skip an injection based on GI symptoms alone without speaking to a clinician first. The titration schedule exists for good reasons, and unguided changes can complicate your treatment course.
Most diarrhoea on tirzepatide does not need emergency attention. It does need prompt clinical review if: it is severe or has lasted more than a week; you are unable to keep fluids down; you notice signs of dehydration such as very dark urine, dizziness or confusion; or you are in a group where fluid loss carries additional risk (older adults, people with kidney disease, or people on medicines that interact with dehydration such as certain blood pressure drugs or diuretics).
One symptom that should not be conflated with ordinary diarrhoea is severe, persistent abdominal pain that extends towards the back, particularly if accompanied by vomiting. In January 2026 the MHRA issued a Drug Safety Update drawing attention to acute pancreatitis as an infrequent but serious risk with GLP-1 medicines including tirzepatide, and a full overview of tirzepatide side effects including diarrhoea is available if you want to understand the broader safety picture before seeking help. You can read the MHRA update directly on the MHRA Yellow Card site, which is also where you or your prescriber can report any suspected side effect from your treatment. Reporting is straightforward and genuinely helps regulators build a clearer safety picture for everyone on these medicines.
If you are unsure whether what you are experiencing requires attention, contact your prescriber or call 111. Getting it checked costs very little; leaving a serious symptom unassessed costs more.
Every repeat supply of tirzepatide through nume involves a fresh clinical review before anything is dispensed) there are no automatic renewals. That review is the right moment to raise persistent or recurrent GI symptoms, including diarrhoea that has not fully settled. A prescriber can consider whether the titration pace suits you, whether any dietary or timing adjustments are worth trying, or whether symptoms warrant a different clinical decision.
If you have questions before your next review, our aftercare team is available seven days a week. For broader context on weight management treatment options or to understand more about how tirzepatide works as a licensed treatment, those pages cover the background in full. If you have not yet started treatment and are researching what to expect, speaking to our prescribers as part of a free consultation is the most direct way to get answers specific to your health history.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.